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Leucine-rich repeat-containing G protein-coupled
receptors 4–6 (LGR4–LGR6) are receptors for
R-spondins, potent Wnt agonists that exert pro-
found trophic effects on Wnt-driven stem cells com-
partments. We present crystal structures of a
signaling-competent fragment of R-spondin 1
(Rspo1) at a resolution of 2.0 A˚ and its complex
with the LGR5 ectodomain at a resolution of 3.2 A˚.
Ecto-LGR5 binds Rspo1 at its concave leucine-
rich-repeat (LRR) surface, forming a dimeric 2:2
complex. Fully conserved residues on LGR4–LGR6
explain promiscuous binding of R-spondins. A
phenylalanine clamp formed by Rspo1 Phe106 and
Phe110 pinches Ala190 of LGR5 and is critical for
binding. Mutations related to congenital anonychia
reduce signaling, but not binding of Rspo1 to
LGR5. Furthermore, antibody binding to the
extended loop of the C-terminal LRR cap of LGR5
activates signaling in a ligand-independent manner.
Thus, our data reveal binding of R-spondins to
conserved sites on LGR4–LGR6 and, in analogy to
FSHR and related receptors, suggest a direct
signaling role for LGR4–LGR6 in addition to its for-
mation of Wnt receptor and coreceptor complexes.INTRODUCTION
Vertebrate genomes encode four secreted R-spondin proteins
(Rspo1–Rspo4), each defined by two N-terminal Furin (Fu)
domains and a thrombospondin (Tsp) domain. Functionally,
R-spondin proteins act as potent enhancers of Wnt signals
(Kazanskaya et al., 2004). Indeed, Rspo1 strongly promotes
proliferation of the Wnt-dependent intestinal-crypt stem cell
compartment in vivo (Kim et al., 2005) and in vitro (Sato
et al., 2009). This activity can be attributed to the two Fu
domains, because a Fu1-Fu2 fragment of Rspo1 retained
full signaling activity (Kim et al., 2008; Li et al., 2009).CR-spondin mutations have been found in two hereditary
syndromes in humans. Rspo1 is mutated in a recessive
syndrome characterized by XX sex reversal, palmoplantar
hyperkeratosis, and squamous cell carcinomas (Schuijers
and Clevers, 2012). Mutations in the Rspo4 gene result in
congenital anonychia, a severe hypoplasia of fingernails and
toenails (Blaydon et al., 2006; Bru¨chle et al., 2008; Wasif
and Ahmad, 2013).
The Wnt target gene leucine-rich repeat-containing G pro-
tein-coupled receptor 5 (Lgr5) encodes a serpentine receptor
that is exquisitely specific to Wnt-dependent stem cells of a se-
ries of adult tissues, including small intestine and colon (Barker
et al., 2007), stomach (Barker et al., 2010), hair follicle (Jaks
et al., 2008), liver (Huch et al., 2013), kidney (Barker et al.,
2012), and mammary gland (Plaks et al., 2013). The LGRs
form a small family of seven-transmembrane (7TM) receptors
that include the follicle-stimulating hormone, luteinizing hor-
mone, and thyroid-stimulating hormone receptors (FSHR,
LHR, and TSHR, also referred to as LGR1–LGR3, respectively)
(Hsu et al., 1998). LGR5 (as well as its homologs LGR4 and
LGR6) binds R-spondins with high affinity, thus mediating R-
spondin input into the canonical Wnt pathway (Carmon et al.,
2011; de Lau et al., 2011; Glinka et al., 2011). Indeed, LGR4
and LGR5 proteins physically reside within Frizzled/LRP recep-
tor complexes (de Lau et al., 2011). Whereas deletion of the
Lgr5 gene in the intestine has little effect, mutation of Lgr4
(which is expressed by all crypt cells) severely decreases crypt
proliferation (Mustata et al., 2011). Double Lgr4 and Lgr5
knockout completely abolishes proliferation (de Lau et al.,
2011), implying that R-spondins are major drivers of Wnt-
dependent crypt self-renewal.RESULTS AND DISCUSSION
Structures of Free and Bound Rspo1
We sought to address the crystal structure of the Fu1-Fu2
fragment of Rspo1 and its complex with the ligand-binding ecto-
domain of LGR5. A crystal structure of Rspo1-Fu1Fu2 (residues
31–145) was derived at a resolution of 2.0 A˚ (Figure 1A).
Fu domains are rich in cysteine-knotted b-hairpins. In
contrast to earlier mass-spectrometry analysis (Li et al., 2009),ell Reports 3, 1885–1892, June 27, 2013 ª2013 The Authors 1885
Figure 1. Structure of Rspo1 and the Complex of Rspo1 with Ecto-LGR5
(A) Structure of (unbound) Rspo1-Fu1Fu2 (residues 31–145) at 2 A˚ resolution. Indicated are disulphide bonds (ball and stick) and disordered residues (dashed
line).
(B) Overlay of bound and unbound Rspo1. The arrow indicates a hinge around which the orientation between the Fu1 and Fu2 domains differs by 90 between
the LGR5-bound and unbound structure of Rspo1.
(C) Structure of the LGR5 ectodomain (residues 22–543) in complex with the Rspo1 Fu1-Fu2 domains at 3.2 A˚ resolution in two views, one without and one with
surface representation. Domain compositions of LGR5 and Rspo1 are indicated schematically.
See also Figures S1, S2, S3, S4, S5, S6, and S11.Rspo1-Fu1Fu2 displayed disulphide-bond patterns common to
other Fu domains (Garrett et al., 1998; Ogiso et al., 2002). Each
Fu domain formed a leaflet consisting of three b-hairpins con-
nected by disulphide bonds (Figure S1). The sets of Fu1 and
Fu2 b-hairpins were oriented at 90 to each other in unbound
Rspo1. Next, we determined the structure of this Rspo1 frag-
ment in complex with the LGR5 ectodomain (residues 22–543)
at 3.2 A˚ resolution (Figures 1B and 1C). In the complex, a twist
due to a rotation around the longitudinal axis of Rspo1 aligned
the two sets of b-hairpins, thus flattening the shape of Rspo1
when bound to LGR5.
Structure of the LGR5-Rspo1 Complex
Rspo1-Fu1Fu2 binds the ecto-LGR5 domain with a KD of 2–3 nM
(de Lau et al., 2011; Glinka et al., 2011). We observed dimeric,
2:2, arrangements of the complex in four crystal structures,
determined up to 3.2 A˚ resolution (Figure 1C and Figure S2).
Size-exclusion chromatography indicated 1:1 complexes (Fig-
ure S3). In agreement with a physiological existence of LGR
dimers on cells, previous mass-spectrometry analysis has re-1886 Cell Reports 3, 1885–1892, June 27, 2013 ª2013 The Authorsvealed interactions between LGR4 and LGR5 in the cell mem-
brane (de Lau et al., 2011). In the absence of the cell membrane
and the 7TM region, the interaction between the LGR ectodo-
mains may be lost in solution. Of note, a similar observation
was made for FSHR (Fan and Hendrickson, 2005) and TLR5
(Yoon et al., 2012).
The LGR5 ectodomain adopted a typical horseshoe-shaped
structure consisting of the 17 leucine-rich repeat (LRR) units
(Figure 1C and Figure S4). The N-terminal and C-terminal caps
(N- and C-caps) were similar to those of FSHR (Jiang et al.,
2012) (Figures S4C and S4D). A long loop in the C-cap con-
tained an a helix but was largely disordered, possibly adopting
a stable structure upon interaction with the extracellular loops
of the 7TM region. The LRR curve was kinked and twisted by
20 between LRR10 and LRR11. This kink coincided with a
marked sequence variation in LRR9 and LRR10, wherein two
bulky phenylalanines occupied the positions of canonical leu-
cines (Figures S4A and S5). Several LRR-containing receptors
show curvatures similar to the N-terminal LRR1–LRR10 or the
C-terminal LRR11–LRR17 (Figure S6). Due to the kink and
Figure 2. LGR5-Rspo1 Interfaces
(A) Overview of three binding interfaces between Rspo1 and LGR5. Shown are the contact footprints of Rspo1 on LGR5; contacts for Fu2 are indicated in green
and for Fu1 in magenta (with cis LGR5) and blue (with trans LGR5).
(B) Interactions between Fu2 of Rspo1 with LGR5.
(C) Interactions between Fu1 of Rspo1 with LGR5 (cis).
(D) TOPFlash results for purified Rspo1 mutants in the Fu2 domain from 1.5 to 200 nM (with K115E as additional control). Error bars represent SD (n = 3).
(E) TOPFlash results obtained by transfection-mediated introduction of 0.012 to 15 ng of wild-type and LGR5 variants, mutated on residues interacting with
Rspo1. One day prior to introduction of LGR5 and reporter plasmids, cells were transfected with LGR4-specific siRNA. The 15 ng results are shown. Error bars
represent SD (n = 3).
(F) TOPFlash results for Rspo1 mutants in the Fu1 domain (concentrations as in D). Error bars represent SD (n = 3).
(G) Small-intestinal organoid growth in the presence of wild-type or Rspo1 mutants.twisting of the C-terminal LRR11–LRR17 (yielding an overall
twist of 45), the protomers bent toward each other in the
dimer. Contact points in the dimer bridged LRR10 to LRR17
(Figure S7A) with a large ‘‘open’’ area between the dimer part-
ners, except for an H-bonded interaction between Tyr-361
and its dimeric partner at the center.CLGR5-Rspo1 Binding Interfaces
The ecto-LGR5 and Rspo1-Fu1Fu2 complex observed in the
crystals revealed three receptor-ligand contact sites (Figures
2A–2C). Two adjoining sites were formed by the concave surface
of the LRR3–LRR9 of LGR5with Fu2 and Fu1 of Rspo1, burying a
total surface area of 870 A˚2. A third site (burying 340 A˚2) wasell Reports 3, 1885–1892, June 27, 2013 ª2013 The Authors 1887
formed ‘‘in trans’’ between Rspo1-Fu1 and the second copy of
LGR5.
In the first contact site, phenylalanine residues 106 and 110
of the Rspo1-Fu2 domain formed a clamp-like arrangement
around Ala190 of LGR5 (Figure 2B). Ala190 was surrounded by
a hydrophobic rim formed by Cb atoms and/or side chains of
His166, Trp168, Gln189, Val213, Val214, and His216. On the
side of this hydrophobic patch, glutamates 237 and 261 of
LGR5 formed H-bonds and salt bridges with His108 and
Asn109 from the 106FSHNF110 loop and with Arg-124 from a
neighboring loop. All these contact residues of LGR5 are strictly
conserved among LGR4–LGR6 (Figure S5). Between the R-
spondins, Phe106 and Phe110 are fully conserved, the inter-
vening residues are all hydrophilic or charged, and position
124 is either an arginine or a lysine (Figure S1B). We generated
the Rspo1-Fu1Fu2 mutants F106E and F110E and found that
these had no activity in the TOPFlash Wnt reporter assay (Fig-
ure 2D). Mutations A190D and V214W of LGR5, disrupting the
shallow hydrophobic bowl, showed reduced signaling activity
(Figure 2E).
Residues from Rspo1-Fu1 and LGR5 residues from the
‘‘lower’’ part of the concave surface of LRR3–LRR7 formed the
second contact site (Figure 2C). This site was predominantly of
charged character. Again, the LGR5 residues at the interface
were strictly conserved between LGR4–LGR6. These residues
were Asn123, Arg144, Asp146, Asp170, Asp171, Leu195,
His218, and Asn219. The corresponding Rspo1 residues were
Lys59, Ser78, Asp85, Arg87, Asn88, and Asn92. Lys59 and
Arg87, at the center of this site, were conserved as lysines or
arginines between all four R-spondins. Charge-reversal muta-
tions R87E and K59E showed reduced activity, confirming their
role in the interaction (Figure 2F). Mutation of the nonconserved
Asn88 (on the side of the interface) had no effect on Rspo1 activ-
ity. LGR5 mutants D146F and D170F had lost all signaling activ-
ity, whereasmutants R144E and D171A showed reduced activity
(Figure 2E). We concluded that Rspo1 utilizes both its Fu1 and
Fu2 domains to bind the ectodomain of LGR5 at sites that are
fully conserved between LGR4–LGR6. This was in agreement
with the observed lack of specificity of each of the R-spondins
for LGR4–LGR6 (Carmon et al., 2011; de Lau et al., 2011; Glinka
et al., 2011). In vitro ‘‘minigut’’ culture, which depends entirely on
functional R-spondin (Sato et al., 2009), confirmed that Rspo1-
FuFu2 stimulated organoid growth and two binding-defective
Rspo1-Fu1Fu2 F106E and F110E mutants failed to support
growth (Figure 2G).
The trans Site and Dimer Interface
In the third site, Rspo1-Fu1 contacted the dimeric partner LGR5
at the last LRR and short a helix of the C-cap (Figure 3A). The
interface was formed by LGR5 residues from the C-cap,
Gln457, Ser458, Leu459, and Tyr477 and Rspo1 residues
Asn51, Leu54, Leu64, Gln71, Asn88, and Met91. However, in
several protein copies in the crystal structures, we observed
disorder at this interface (Figure S8). The side chain of Rspo1
Gln71 made a H-bond to backbone carbonyl oxygen of the
Tyr477 of LGR5 (Figure 3A); both residues are strictly conserved
between Rspo1–Rspo4 and LGR4–LGR6, respectively. Gln71 of
Rspo1 coincides with the position of one of the four Rspo4 mu-1888 Cell Reports 3, 1885–1892, June 27, 2013 ª2013 The Authorstations described in patients with congenital anonychia (Blaydon
et al., 2006; de Lau et al., 2012). The four related residues are
Arg66, Arg70, Gln71, and Gly73, which were located in the
second b-hairpin loop of Rspo1-Fu1. Anonychia mutants
R66W, Q71R, R70C, and G73R and related mutations in
Rspo1-Fu1Fu2 did not affect binding to ecto-LGR5, but showed
reduced signaling activity (Figures 3B and 3C). Q71R and G73R
point toward the ‘‘trans’’ interface and may disrupt interactions.
LGR5 mutations in the trans site showed both reduced (S458R)
and enhanced (L459R) TOPFlash activity (Figure S7); these find-
ings could not be corroborated further due to lack of expression
on the cell surface of the tested mutants. Next, we mutated
LGR5 residues in the dimer interface (Figure S7). Residues
Tyr289, Asp290, and His454 were observed at the LGR5-LGR5
dimer interface (Figure S7A). Mutation Y289A/D290A, Y289W/
D290A, or H454A did not significantly reduce TOPFlash activity
(Figure S7B), indicating that the receptor-receptor interface
observed in the crystal structure is not critical and that dimer
formation may depend on receptor-receptor interactions in the
membrane (de Lau et al., 2011).
Activation by Antibody Binding to Disordered C-Cap
Loop in the Absence of Rspo1
Ligand-activated signaling is well established for the glycohor-
mone receptors FSHR, TSHR, and LHR (Jeoung et al., 2007;
Ryu et al., 1998; Simoni et al., 1997). However, a downstream
Gprotein has not been identified for LGR5. It is unknownwhether
LGR5, or its homologs LGR4 and LGR6, is directly involved in
transmembrane signaling, or whether the receptor serves to
capture its ligand and affect Wnt signaling solely through
ternary-complex formation, with LRP5/LRP6 (Wei et al., 2007),
Frizzled (Nam et al., 2006), and RNF43/ZNRF3 (Hao et al.,
2012), for example. We tested a series of LGR5-specific mono-
clonal antibodies and observed that three of them (1D9, RD20,
and RD42) induced TOPFlash activity in human embryonic kid-
ney 293 cells (HEK293 cells) stably expressing LGR5 in the
absence of R-spondins (Figures 4A and 4B). The epitopes of
these antibodies were mapped onto a flexible region in the
ecto-LGR5 C-cap loop (notably, the C-cap was not required
for ligand binding as shown for a shortened construct in Fig-
ure S3). In contrast, antibody 4D11, which binds to LRR9–
LRR11, showed no activity in the TOPFlash assay (data not
shown). For the glycohormone receptors, this region (referred
to as the hinge region) has been implied to have an autoinhibi-
tory, reverse-agonistic role (Agrawal and Dighe, 2009; Majumdar
et al., 2012; Mueller et al., 2010; Vlaeminck-Guillem et al., 2002;
Zeng et al., 2001; Zhang et al., 2000). Similarly, antibodies
against FSHR (Majumdar et al., 2012) and TSHR (Majumdar
and Dighe, 2012) bind between the LRR and 7TM regions and
activate signaling, putatively through inducing a conformational
change that alleviates the autoinhibitory activity. The TOPFlash
activity upon antibody binding may indicate a similar process
in LGR5. Moreover, the positions of the anonychia-related muta-
tions provide further indication of interactions beyond the con-
tact sites formed by the ecto-LGR5, with residues Arg60 and
Arg77 pointing away from the trans site to where the extended
C-cap loop or 7TM is expected (see Figure S9 for a presentation
of a hypothetical ectodomain and 7TM region arrangement). To
Figure 3. trans and Dimer Interactions
(A) trans contact site between Rspo1-Fu1 and the neighboring C-cap of LGR5; positions of anonychia-related (Rspo4) residues are indicated by red spheres.
(B) Binding assay of Rspo1 anonychia location-specificmutations, present in conditionedmedia (middle panel), to immobilized LGR5 ectodomain (top panel). The
bottom panel shows the amount of protein captured. Actual patient mutations are indicated (*). G82E is used as positive control, and F106E and F110E are used
as negative controls. HRP, horseradish peroxidase; HIS, histidine; IP, immunoprecipitation.
(C) TOPFlash assay using conditioned media derived from wild-type and Rspo1 mutants. Error bars represent SD (n = 3).
See also Figures S7 and S8.verify a role of the 7TM in signaling, we rigorously substituted
residues 562–907 of LGR5 with the corresponding region of
an unrelated, single-pass membrane protein, GPA33. Fluores-
cence-activated cell sorting (FACS) analysis showed that the
chimeric receptor is expressed on the cell surface (Figure S10A),
and Rspo1-alkaline phosphate staining on the cell surface indi-
cates that the Rspo1 is able to bind to the chimeric receptor (Fig-
ure S10B). However, TOPFlash activity reduced to basal levels
(Figure S10C), supporting the notion that binding of Rspo1 to
the LGR5 ectodomain is not sufficient for signaling.
Concluding Remarks
The current structural analysis of Rspo1 in complex with the
ectodomain of LGR5 provides a framework from which to build
insights into the molecular mechanism by which these two mol-
ecules support a wide range of Wnt-dependent stem cell types.
R-spondins have been reported to interact with additional mem-
brane receptors such as LRP5/LRP6 (Wei et al., 2007), Frizzled
(Nam et al., 2006), RNF43/ZNRF3 (Hao et al., 2012), and Synde-
can-4 (Ohkawara et al., 2011). The Wnt agonist Norrin binds
LGR4–LGR6 in addition to its interaction with Frizzled4 (DengCet al., 2013). These proteins either compete for binding or, poten-
tially, form complexes. The short R-spondin Fu1Fu2 fragment
suffices for full activity in assays in vitro (Kim et al., 2008; Li
et al., 2009). Thoughmost of the Fu1-Fu2 surfaces of R-spondins
will be in contact with LGR4–LGR6, additional interactions with
Fu1 and Fu2 domains may allow the formation of ternary com-
plexes with LRP5/LRP6, Frizzled, or RNF43/ZNRF3, with or
without changing the overall arrangement of the R-spondin-
LGR4–LGR6 complexes. Furthermore, in full-length R-spondins,
the Tsp and C-terminal tail, not studied here, probably point out-
ward from the complex, providing additional potential contact
sites close to the membrane surface—for Syndecan-4, for
instance (Ohkawara et al., 2011) (Figure S9). Ligand-indepen-
dent signaling through antibody binding and residues in the C-
cap region that are critical for signaling are features reminiscent
of signaling in FSHR, TSHR, and LHR (Mizutori et al., 2008; Mu-
eller et al., 2010). Critical interactions beyond ligand binding to
the LRR of LGR5 are further supported by the location of the ano-
nychia-related (Rspo4) mutations (Blaydon et al., 2006; de Lau
et al., 2012). Taken together, our data indicate that R-spondins
bind tightly to the strictly conserved binding sites formed byell Reports 3, 1885–1892, June 27, 2013 ª2013 The Authors 1889
Figure 4. Ligand-Independent Antibody
Activation of LGR5
(A) Epitopes of antibodies RD20, RD42, and 1D9
mapped onto ecto-LGR5 (the precise location of
this protruding region varies among crystal struc-
tures; see Figure S2B).
(B) TOPFlash assay for LGR5-specific antibodies
RD20, RD42, and 1D9 in the presence of Wnt3a,
but in the absence of R-spondins. Error bars
represent SD (n = 3).
See also Figures S2, S9, and S10.LRR3–LRR9 of LGR4–LGR6 and thatmonomeric 1:1 interactions
are sufficient for this binding to occur. Full-length LGR4–LGR6
molecules, however, dimerize to establish the trans contact sites
that are implied in signaling. Signaling may also occur upon anti-
body binding to the C-cap loop region independent of binding R-
spondins. In analogy to FSHR, TSHR, and LHR (Mueller et al.,
2010; Vassart et al., 2004), this binding may induce conforma-
tional changes alleviating the putative autoinhibitory, reverse-
agonistic activity. Thus, these data suggest a direct role of
signaling by the LGR4–LGR6 in addition to ternary-complex for-
mations. Hence, a bewildering complexity exists at the level of
the initiation of Wnt signals at the cell surface because of the ex-
istence of 19 Wnts, 10 Frizzleds, and 2 LRP Wnt coreceptors. A
variety of secreted and membrane-bound Wnt agonists and an-
tagonists add a further level of complexity. The facultative R-
spondin-LGR receptormodule appears to represent a vertebrate
invention for magnifying Wnt signal strength and thus enlarging
stem cell compartments. Recent structures have been resolved
for Wnt-Frizzled (Janda et al., 2012) and Dkk1-LRP (Ahn et al.,
2011; Bourhis et al., 2011; Chen et al., 2011; Cheng et al.,
2011). Many additional studies will be required for understanding
the inner workings of what must be among the most complex re-
ceptor-ligand systems in animal biology.EXPERIMENTAL PROCEDURES
Ecto-LGR5 (residues 22–543) and Rspo1-Fu1Fu2 (residues 31–145) proteins
were produced recombinantly in HEK293 N-acetylglucoaminyltransferase
I-deficient (GnTI) Epstein-Barr virus nuclear antigen I (EBNA) cells, purified
to homogeneity, and crystallized with the hanging-drop vapor-diffusion
method. Diffraction data were collected at the Swiss Light Source (SLS) in Vil-
ligen, Switzerland and at the European Synchrotron Radiation Facility (ESRF)
in Grenoble, France. The structures of Rspo-Fu1Fu2 and the ecto-LGR5-
Rspo-Fu1Fu2 complex were determined by experimental phasing and molec-
ular replacement, respectively. Diffraction-data and refinement statistics are
provided in Table S1; examples of the electron densities are shown in Fig-
ure S11. Monitoring the potential of wild-type and mutated variants of
Rspo1-Fu1Fu2 to enhance Wnt signals was done by employing the TCF-
dependent TOP luciferase assay in HEK293T cells (Staal et al., 1999).
Measuring the ability of mutated versions of the LGR5 to transmit Rspo1-
Fu1fu2-driven signaling was performed using the same luciferase assay but
with simultaneous small interfering RNA (siRNA)-driven knockdown of endog-
enous LGR4. The LGR5-binding ability of Rspo1-Fu1Fu2 proteins mutated in
the LGR5-interacting domain and Rspo1-Fu1Fu2 mutants representing
congenital anonychia mutations were tested in an immunoprecipitation exper-
iment with the ectodomain of LGR5 coated on agarose beads. Additional de-
tails are available in the Extended Experimental Procedures.1890 Cell Reports 3, 1885–1892, June 27, 2013 ª2013 The AuthorsACCESSION NUMBERS
The Protein Data Bank (PDB) accession numbers for the coordinates and
structure factors of Rspo1 and LGR-Rspo1 reported in this paper are 4BSO,
4BSP, 4BSR, 4BSS, 4BST, and 4BSU.
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